Drugwrite Services India Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.10 M
- Company Age 16 Year, 7 Months
- Last Filing with ROC 31 Mar 2022
- Revenue Growth 95.77%
- Profit Growth 103.17%
- Ebitda 116.25%
- Net Worth 38.63%
- Total Assets -13.67%
About Drugwrite Services India
Drugwrite Services India Private Limited (DSIPL) is a Private Limited Indian Non-Government Company incorporated in India on 03 July 2008 and has a history of 16 years and seven months. Its registered office is in Bangaluru, Karnataka, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Narayanan Booban and Sindu Sukumaran serve as directors at the Company.
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U85100KA2008PTC047029
- Company No.
047029
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 Jul 2008
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Who are the key members and board of directors at Drugwrite Services India?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Narayanan Booban  | Managing Director | 26-Nov-2008 | Current |
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sindu Sukumaran | Director | 01-Dec-2008 | Current |
Financial Performance of Drugwrite Services India.
Drugwrite Services India Private Limited, for the financial year ended 2017, experienced significant growth in revenue, with a 95.77% increase. The company also saw a substantial improvement in profitability, with a 103.17% increase in profit. The company's net worth Soared by an impressive increase of 38.63%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Drugwrite Services India?
In 2017, Drugwrite Services India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Biztalk Media Private LimitedNarayanan Booban is a mutual person
Modives Tech Private LimitedNarayanan Booban is a mutual person
- Businessbrahma Worldwide Media Private Limited
Narayanan Booban is a mutual person
- Directorin Business Consulting Private Limited
Narayanan Booban is a mutual person
- Aozoi Private Limited
Narayanan Booban is a mutual person
- Aozoi Selo Foundation
Narayanan Booban is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Drugwrite Services India?
Unlock and access historical data on people associated with Drugwrite Services India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Drugwrite Services India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Drugwrite Services India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
